Netherlands-based ambulatory and ophthalmology clinic group Bergman Clinics, currently exploring a sale that could raise over €1bn, has acquired German aesthetic surgical treatments platform Medical One.
The quick rise of health apps has meant processes for approval and reimbursement have largely replicated ones for bringing new drugs to market. That is now starting to change, with many of the new reimbursement schemes recognising a need for real-world evidence over randomised clinical trials and new standards being created specifically for apps.
Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.
Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.
The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite.
Preliminary bids for Dutch, Nordic and German ambulatory and ophthalmology clinic group Bergman Clinics were due last week, HBI is told, with big-hitting PE firms expected to make offers.
Dr. Markus Hamm is set to take over as CEO of Ober Scharrer Germany (OSG) next month, as the ophthalmology specialist reorganises the management of its German business.
A detailed draft on German long-term care (LTC) insurance reform is expected in the coming days, HBI hears. The government plans to cap the out-of-pocket spend on residential care to €700 a month, three times less than the current average spend.
Multiple sources tell HBI that DACH psychiatry and acute hospital group Ameos is preparing for sale or refinancing. The group vehemently denies it is preparing for sale.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
